| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 363,540 | 127,556 | 115,933 | 170,688 | | Cost of Revenue | 237,912 | 86,741 | 84,718 | 128,935 | | | Gross Profit | 125,628 | 40,815 | 31,215 | 41,753 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 66,739 | 43,195 | 40,883 | 45,473 | | Non Recurring |
-
|
-
|
-
| 33,523 | | Others | 1,303 | 1,384 | 1,404 | 1,692 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 57,586 | (3,764) | (11,072) | (38,935) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 53,987 | (3,764) | (11,072) | (38,935) | | Interest Expense | (1,707) | 1,022 | 685 | 1,403 | | Income Before Tax | 55,694 | (4,786) | (11,757) | (40,338) | | Income Tax Expense | 23,391 | (2,010) | (4,938) | (8,213) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 32,303 | (2,776) | (6,819) | (32,125) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 32,303 | (2,776) | (6,819) | (32,125) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $32,303 | ($2,776) | ($6,819) | ($32,125) |
|
0.31% Nasdaq 0.00%
Income Statement
